1. Home
  2. EDSA vs BTBD Comparison

EDSA vs BTBD Comparison

Compare EDSA & BTBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • BTBD
  • Stock Information
  • Founded
  • EDSA 2015
  • BTBD 1987
  • Country
  • EDSA Canada
  • BTBD United States
  • Employees
  • EDSA N/A
  • BTBD N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • BTBD Restaurants
  • Sector
  • EDSA Health Care
  • BTBD Consumer Discretionary
  • Exchange
  • EDSA Nasdaq
  • BTBD Nasdaq
  • Market Cap
  • EDSA 6.2M
  • BTBD 6.6M
  • IPO Year
  • EDSA N/A
  • BTBD 2021
  • Fundamental
  • Price
  • EDSA $1.83
  • BTBD $1.38
  • Analyst Decision
  • EDSA Strong Buy
  • BTBD
  • Analyst Count
  • EDSA 1
  • BTBD 0
  • Target Price
  • EDSA $21.00
  • BTBD N/A
  • AVG Volume (30 Days)
  • EDSA 35.8K
  • BTBD 4.0K
  • Earning Date
  • EDSA 05-14-2025
  • BTBD 05-15-2025
  • Dividend Yield
  • EDSA N/A
  • BTBD N/A
  • EPS Growth
  • EDSA N/A
  • BTBD N/A
  • EPS
  • EDSA N/A
  • BTBD N/A
  • Revenue
  • EDSA N/A
  • BTBD $14,864,398.00
  • Revenue This Year
  • EDSA N/A
  • BTBD N/A
  • Revenue Next Year
  • EDSA N/A
  • BTBD N/A
  • P/E Ratio
  • EDSA N/A
  • BTBD N/A
  • Revenue Growth
  • EDSA N/A
  • BTBD 4.71
  • 52 Week Low
  • EDSA $1.55
  • BTBD $1.00
  • 52 Week High
  • EDSA $5.59
  • BTBD $2.02
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 29.28
  • BTBD 61.91
  • Support Level
  • EDSA $1.88
  • BTBD $1.31
  • Resistance Level
  • EDSA $2.05
  • BTBD $1.40
  • Average True Range (ATR)
  • EDSA 0.08
  • BTBD 0.07
  • MACD
  • EDSA -0.00
  • BTBD 0.01
  • Stochastic Oscillator
  • EDSA 0.00
  • BTBD 87.42

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About BTBD BT Brands Inc.

BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.

Share on Social Networks: